Dr. Sanket Mehta

Dr Sanket Mehta is a renowned Surgical Oncologist and Robotic Surgery Specialist with over 15 years of experience. He is currently working as a Consultant at:

• Sir H. N. Reliance Foundation Hospital
• Saifee Hospital
• Breach Candy Hospital Trust
• Jaslok Hospital and Research Centre, Tardeo
• Speciality Surgical Oncology Hospital and Research Centre

He was associated with Epic Hospital.

Dr Mehta has performed 1000+ cancer surgeries, including 1600 Cytoreductive Surgeries (CRS) and 700 HIPEC procedures. He has independently carried out 800+ cytoreductive surgeries and 450+ laparoscopic and robotic cancer surgeries.

He is widely recognised as the pioneer in establishing HIPEC for recurrent ovarian cancer in India.

His speciality interests are:

1. Laparoscopic and Robotic Surgery for Cervical and Endometrial Cancers
   
2. Advanced and Recurrent Ovarian Cancer Surgery
   
3. CRS and HIPEC for Primary Peritoneal and Recurrent Ovarian Cancers
   
4. Laparoscopic and Robotic Colorectal Surgery
   
5. Laparoscopic Retroperitoneal Lymph Node Dissection
   
6. Cytoreductive Surgery, HIPEC, and PIPAC
   
7. Gastrointestinal and Gynaecological Cancer Surgery
   
8. Retroperitoneal Tumours and Complex Abdominal Resections

Dr Sanket Mehta completed his MBBS from Lokmanya Tilak Municipal Medical College, Mumbai, followed by:

• MS in General Surgery from Tata Memorial Hospital, Mumbai
• Fellowship in Laparoscopic and Robotic Colorectal Surgery from St. Mary’s Hospital, Catholic University of Korea, Seoul
• Fellowship in Gastrointestinal Oncology and Cytoreductive Surgery from CRLC Val d’Aurelle, Montpellier, France
• Fellowship in Digestive and Minimal Invasive Surgery from L’Hopital Saint-Eloi, CHU Montpellier, France
• Paediatric Haematology Oncology – Bone Marrow Transplant Fellowship from National University Hospital, Singapore
• ECMO Clinical Research Fellowship from Tata Memorial Hospital, Mumbai
• IOP Fellowship from St. Jude Children’s Research Hospital, USA
• Diploma in Clinical Research
• Professional Certification in CAR-T Cell and Gene Therapy (Singapore)

Dr Mehta has extensive international exposure, having trained and worked across France, South Korea, Singapore, and the United States. He has actively contributed to academic oncology through peer-reviewed international research, with 40+ international publications.

His notable research papers include:

• Do all patients that undergo a complete secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer benefit from it
  
• Total Parietal Peritonectomy with acceptable morbidity after neoadjuvant chemotherapy for advanced ovarian cancer
  
• Paul Sugarbaker and Peritoneal Surface Oncology in India
  
• The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the treatment of peritoneal metastases

Dr Sanket Mehta is a Founder Member and President of the Society of Peritoneal Surface Oncology of India (SPSOi) and currently leads the first dedicated Peritoneal Surface Oncology Department in India at Saifee Hospital.

He is also an member of the:

• Asian Peritoneal Surface Malignancy Group (APSMG)
• American Society of Peritoneal Surface Malignancy (ASPSM)

His accolades and achievements include:

• Young Achievers Award by JCI
  
• Rotary International Ambassadorial Scholarship (2009–2010)
  
• First surgeon to present HIPEC for colorectal carcinomatosis at ASCO-GI
  
• First surgeon in India to perform TEO surgeries including TATME
  
• Founder Member and Trustee of Cancer Charity Trust
  
• Founder Member of Asha Foundation
  
• Chief of Division of Peritoneal Surface Oncology at Saifee Hospital

His command of English, Hindi, and Marathi reassures patients, making them comfortable enough to express their concerns freely.

For information regarding Dr Sanket Mehta’s contact details, OPD timings, consultation fees, or to book priority appointments with a seamless experience, patients are encouraged to connect with the HexaHealth medical team.